Mer­ck KGaA hands off its CAR-T R&D op­er­a­tions to In­trex­on in $175M deal

Mer­ck KGaA is bow­ing out of the CAR-T de­vel­op­ment busi­ness, hand­ing over its rights to In­trex­on $XON in ex­change for $150 mil­lion batch of stock.

The Ger­man Mer­ck is char­ac­ter­iz­ing the move as an R&D sim­pli­fi­ca­tion process, stay­ing fo­cused where they be­lieve they can make the most progress. And the deal comes three years af­ter the two com­pa­nies al­lied on CAR-T, with In­trex­on con­tribut­ing its tech — in­clud­ing Sleep­ing Beau­ty — for the pre­clin­i­cal work un­der­way.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.